The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer

被引:118
|
作者
Bennett, Richard L.
Swaroop, Alok
Troche, Catalina
Licht, Jonathan D. [1 ]
机构
[1] Univ Florida, Dept Med Biochem & Mol Biol, Gainesville, FL 32610 USA
来源
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE | 2017年 / 7卷 / 06期
关键词
H3K36; METHYLATION; MULTIPLE-MYELOMA; TRANSCRIPTION ELONGATION; NUP98-NSD1; FUSION; MIDLINE CARCINOMA; GENE-EXPRESSION; NSD1; MUTATIONS; SOTOS-SYNDROME; H3; CHROMATIN;
D O I
10.1101/cshperspect.a026708
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The nuclear receptor- binding SET Domain (NSD) family of histone H3 lysine 36 methyltransferases is comprised of NSD1, NSD2 (MMSET/WHSC1), and NSD3 (WHSC1L1). These enzymes recognize and catalyze methylation of histone lysine marks to regulate chromatin integrity and gene expression. The growing number of reports demonstrating that alterations or translocations of these genes fundamentally affect cell growth and differentiation leading to developmental defects illustrates the importance of this family. In addition, overexpression, gain of function somatic mutations, and translocations of NSDs are associated with human cancer and can trigger cellular transformation in model systems. Here we review the functions of NSD family members and the accumulating evidence that these proteins play key roles in tumorigenesis. Because epigenetic therapy is an important emerging anticancer strategy, understanding the function of NSD family members may lead to the development of novel therapies.
引用
收藏
页数:17
相关论文
共 50 条
  • [31] The plasticity of WDR5 peptide-binding cleft enables the binding of the SET1 family of histone methyltransferases
    Zhang, Pamela
    Lee, Hwabin
    Brunzelle, Joseph S.
    Couture, Jean-Francois
    NUCLEIC ACIDS RESEARCH, 2012, 40 (09) : 4237 - 4246
  • [32] Enzymatic mechanism and product specificity of SET-domain protein lysine methyltransferases
    Zhang, Xiaodong
    Bruice, Thomas C.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (15) : 5728 - 5732
  • [33] CHARACTERIZATION OF THE RECEPTOR-BINDING DOMAIN OF TETANUS TOXIN
    HALPERN, JL
    LOFTUS, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1993, 268 (15) : 11188 - 11192
  • [34] Catalytic roles for carbon-oxygen hydrogen bonding in SET domain lysine methyltransferases
    Couture, Jean-Francois
    Hauk, Glenn
    Thompson, Mark J.
    Blackburn, G. Michael
    Trievel, Raymond C.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (28) : 19280 - 19287
  • [35] Strategy to Target the Substrate Binding site of SET Domain Protein Methyltransferases
    Nguyen, Kong T.
    Li, Fengling
    Poda, Gennadiy
    Smil, David
    Vedadi, Masoud
    Schapira, Matthieu
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2013, 53 (03) : 681 - 691
  • [36] Development and Use of Assay Conditions Suited to Screening for and Profiling of SET-Domain-Targeted Inhibitors of the MLL/SET1 Family of Lysine Methyltransferases
    Ferry, Joseph J.
    Smith, Robert F.
    Denney, Natalie
    Walsh, Colin P.
    McCauley, Lauren
    Qian, Jie
    Ma, Haiching
    Horiuchi, Kurumi Y.
    Howitz, Konrad T.
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2015, 13 (04) : 221 - 234
  • [37] THE ROLE OF RECEPTOR-BINDING IN DRUG DISCOVERY
    SWEETNAM, PM
    CALDWELL, L
    LANCASTER, J
    BAUER, C
    MCMILLAN, B
    KINNIER, WJ
    PRICE, CH
    JOURNAL OF NATURAL PRODUCTS, 1993, 56 (04): : 441 - 455
  • [38] Structure of the SET domain histone lysine methyltransferase Clr4
    Min, JR
    Zhang, X
    Cheng, XD
    Grewal, SIS
    Xu, RM
    NATURE STRUCTURAL BIOLOGY, 2002, 9 (11) : 828 - 832
  • [39] Structure of the SET domain histone lysine methyltransferase Clr4
    Jinrong Min
    Xing Zhang
    Xiaodong Cheng
    Shiv I.S. Grewal
    Rui-Ming Xu
    Nature Structural Biology, 2002, 9 : 828 - 832
  • [40] Role of somatic cancer mutations in human protein lysine methyltransferases
    Kudithipudi, Srikanth
    Jeltsch, Albert
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2014, 1846 (02): : 366 - 379